TELEFLEX INC TFX

Latest FY: 2025 Healthcare Medical Instruments & Supplies
Market Price $137.00
Market Cap $6.07B
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↓-34.6% YoY
$1.99B
3-Yr CAGR: -10.6%
Net Income ↓-1,399.8% YoY
-$905.64M
Net Margin: -45.4%
Free Cash Flow ↑185.9% YoY
$24.10M
FCF Yield: 0.40%
EPS (Diluted) ↓-1,468.2% YoY
$-20.25
Basic: $-20.30
Return on Equity Efficiency
-29.0%
ROA: -601.0%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (TFX)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $1,868.0M $996.2M $237.4M $4.98
FY 2017 $2,146.3M +14.9% $1,171.8M $152.5M -35.7% $3.27 -34.3%
FY 2018 $2,448.4M +14.1% $1,384.4M $200.8M +31.6% $4.29 +31.2% $101.8M $21.0M
FY 2019 $2,595.4M +6.0% $1,491.6M $9.80 +128.4% $96.0M $-6.7M -132.1%
FY 2020 $2,537.2M -2.2% $1,324.9M $335.3M $7.09 -27.7% $79.5M $-11.2M -65.6%
FY 2021 $2,809.6M +10.7% $1,549.6M $485.4M +44.7% $10.23 +44.3% $73.6M $2.0M +117.7%
FY 2022 $2,791.0M -0.7% $1,531.1M $363.1M -25.2% $7.68 -24.9% $70.9M $-8.3M -517.8%
FY 2023 $2,974.5M +6.6% $1,646.9M $356.3M -1.9% $7.53 -2.0% $100.2M $8.8M +206.1%
FY 2024 $3,047.3M +2.4% $1,702.7M $69.7M -80.4% $1.48 -80.3% $98.4M $-28.1M -419.7%
FY 2025 $1,992.7M -34.6% $1,120.8M $-905.6M -1,399.8% $-20.25 -1,468.2% $119.3M $24.1M +185.9%
$

Valuation

Market Price $137.00
Market Cap $6.07B
Enterprise Value $8.34B
P/E Ratio N/A
P/B Ratio 1.94
FCF Yield 0.40%
Dividend Yield 0.99%
Shares Outstanding 44,270,200
%

Profitability & Margins

Gross Margin 56.24%
Operating Margin 5.94%
Net Margin -45.45%
Return on Equity (ROE) -28.98%
Return on Assets (ROA) -601.04%
Asset Turnover 13.22x
Revenue 3-Yr CAGR -10.62%
🛡️

Financial Health & Liquidity

Current Ratio 1.28
Cash Ratio 3.23
Debt / Equity 0.845
Debt / Assets 17.530
Cash & Equivalents $378.56M
Total Debt $2.64B
Book Value / Share $70.58
💧

Cash Flow Efficiency

Operating Cash Flow $119.34M
Capital Expenditures (CapEx) $95.24M
Free Cash Flow $24.10M
OCF / Revenue 5.99%
FCF / Revenue 1.21%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) $-20.25
EPS (Basic) $-20.30
Dividends / Share $1.36
Book Value / Share $70.58
EPS YoY Growth -1,468.24%
🏛️

Balance Sheet (FY 2025)

Total Assets $150.68M
Total Liabilities $117.35M
Stockholders' Equity $3.12B
Current Assets $150.68M
Current Liabilities $117.35M